Role of thyrotropin-releasing hormone in prolactin-producing cell models
- PMID: 26297348
- DOI: 10.1016/j.npep.2015.08.001
Role of thyrotropin-releasing hormone in prolactin-producing cell models
Abstract
Thyrotropin-releasing hormone (TRH) is a hypothalamic hypophysiotropic neuropeptide that was named for its ability to stimulate the release of thyroid-stimulating hormone in mammals. It later became apparent that it exerts a number of species-dependent hypophysiotropic activities that regulate other pituitary hormones. TRH also regulates the synthesis and release of prolactin, although whether it is a physiological regulator of prolactin that remains unclear. Occupation of the Gq protein-coupled TRH receptor in the prolactin-producing lactotroph increases the turnover of inositol, which in turn activates the protein kinase C pathway and the release of Ca(2+) from storage sites. TRH-induced signaling events also include the activation of extracellular signal-regulated kinase (ERK) and induction of MAP kinase phosphatase, an inactivator of activated ERK. TRH stimulates prolactin synthesis through the activation of ERK, whereas prolactin release occurs via elevation of intracellular Ca(2+). We have been investigating the role of TRH in a pituitary prolactin-producing cell model. Rat pituitary somatolactotroph GH3 cells, which produce and release both prolactin and growth hormone (GH), are widely used as a model for the study of prolactin- and GH-secreting cells. In this review, we describe the general action of TRH as a hypophysiotropic factor in vertebrates and focus on the role of TRH in prolactin synthesis using GH3 cells.
Keywords: GH3; PACAP; Prolactin; TRH.
Copyright © 2015 Elsevier Ltd. All rights reserved.
Similar articles
-
Stimulatory effect of pituitary adenylate-cyclase activating polypeptide (PACAP) and its PACAP type I receptor (PAC1R) on prolactin synthesis in rat pituitary somatolactotroph GH3 cells.Mol Cell Endocrinol. 2011 Jun 6;339(1-2):172-9. doi: 10.1016/j.mce.2011.04.010. Epub 2011 Apr 22. Mol Cell Endocrinol. 2011. PMID: 21539889
-
Prolonged stimulation with thyrotropin-releasing hormone and pituitary adenylate cyclase-activating polypeptide desensitize their receptor functions in prolactin-producing GH3 cells.Mol Cell Endocrinol. 2013 Jan 30;365(2):139-45. doi: 10.1016/j.mce.2012.10.006. Epub 2012 Oct 26. Mol Cell Endocrinol. 2013. PMID: 23103668
-
Role of kisspeptin and Kiss1R in the regulation of prolactin gene expression in rat somatolactotroph GH3 cells.Endocrine. 2019 Jan;63(1):101-111. doi: 10.1007/s12020-018-1759-1. Epub 2018 Sep 25. Endocrine. 2019. PMID: 30255291
-
TRH acts as a multifunctional hypophysiotropic factor in vertebrates.Gen Comp Endocrinol. 2009 Oct;164(1):40-50. doi: 10.1016/j.ygcen.2009.05.003. Epub 2009 May 10. Gen Comp Endocrinol. 2009. PMID: 19435597 Review.
-
Interactions between Two Different G Protein-Coupled Receptors in Reproductive Hormone-Producing Cells: The Role of PACAP and Its Receptor PAC1R.Int J Mol Sci. 2016 Sep 26;17(10):1635. doi: 10.3390/ijms17101635. Int J Mol Sci. 2016. PMID: 27681724 Free PMC article. Review.
Cited by
-
Developmental and Functional Effects of Steroid Hormones on the Neuroendocrine Axis and Spinal Cord.J Neuroendocrinol. 2016 Jul;28(7):10.1111/jne.12401. doi: 10.1111/jne.12401. J Neuroendocrinol. 2016. PMID: 27262161 Free PMC article. Review.
-
Expression of PACAP and PAC1 Receptor in Normal Human Thyroid Gland and in Thyroid Papillary Carcinoma.J Mol Neurosci. 2016 Oct;60(2):171-8. doi: 10.1007/s12031-016-0823-7. Epub 2016 Aug 26. J Mol Neurosci. 2016. PMID: 27566169
-
Structural insights into thyrotropin-releasing hormone receptor activation by an endogenous peptide agonist or its orally administered analogue.Cell Res. 2022 Sep;32(9):858-861. doi: 10.1038/s41422-022-00646-6. Epub 2022 Mar 29. Cell Res. 2022. PMID: 35352031 Free PMC article. No abstract available.
-
Association Between Prolactin and Incidence of Cardiovascular Risk Factors in the Framingham Heart Study.J Am Heart Assoc. 2016 Feb 23;5(2):e002640. doi: 10.1161/JAHA.115.002640. J Am Heart Assoc. 2016. PMID: 26908403 Free PMC article.
-
Bromocriptine sensitivity in bromocriptine-induced drug-resistant prolactinomas is restored by inhibiting FGF19/FGFR4/PRL.J Endocrinol Invest. 2025 Jan;48(1):67-80. doi: 10.1007/s40618-024-02408-0. Epub 2024 Jun 26. J Endocrinol Invest. 2025. PMID: 38926262
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous